Jane Street
ELAB icon

Jane Street’s Elevai Labs ELAB Stock Holding History

Jane Street’s Portfolio ELAB Stock Details ELAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$98.6K Buy
8,150
+4,991
+158% +$126K ﹤0.01% 10603
2026
Q1 		$189K Buy
+3,159
New +$405K ﹤0.01% 10205

Other funds holding ELAB

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Jane Street's ELAB Position: Q2 2026 in Review

Jane Street increased its Elevai Labs (ELAB) stake by 158% in Q2 2026, buying an estimated $126K and bringing the position to 8,150 shares worth $98.6K. The position accounts for ﹤0.01% of the portfolio, ranked #10603.

Jane Street first reported a position in ELAB in Q1 2026 and has held it in 2 quarters since. The position peaked at $189K in Q1 2026. 11 funds tracked by Wall St. Rank hold ELAB as of Q2 2026.

  • Jane Street held 8,150 shares of Elevai Labs worth $98.6K as of Q2 2026.
  • Jane Street bought 4,991 Elevai Labs shares in Q2 2026, an estimated $126K.
  • Elevai Labs made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #10603 holding.
  • Jane Street first reported a position in Elevai Labs in Q1 2026 and has held it in 2 quarters since.
  • Jane Street's Elevai Labs position peaked at $189K in Q1 2026.
  • 11 funds tracked by Wall St. Rank held Elevai Labs as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.